From Casetext: Smarter Legal Research

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Jan 16, 2002
Case Number MDL 1290, Misc. No. 99-276 (TFH/JMF) Case Number 1:99-CV-00790 Consolidated with Case Number 99 C2228 U.S. District Court for the Northern District of Illinois (D.D.C. Jan. 16, 2002)

Opinion

Case Number MDL 1290, Misc. No. 99-276 (TFH/JMF) Case Number 1:99-CV-00790 Consolidated with Case Number 99 C2228 U.S. District Court for the Northern District of Illinois

January 16, 2002


ORDER


WHEREAS the Court having reviewed and considered Class Plaintiffs' Motion for Leave to File their Motion to Quash Subpoenas to Absent Class Members and Memorandum in Support thereof under seal,

IT IS HEREBY ORDERED that:

Class Plaintiffs' Motion for Leave to File Under Seal is granted and Class Plaintiffs are given permission to file their Motion to Quash Subpoenas to Absent Class Members and Memorandum in Support thereof under seal.


Summaries of

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Jan 16, 2002
Case Number MDL 1290, Misc. No. 99-276 (TFH/JMF) Case Number 1:99-CV-00790 Consolidated with Case Number 99 C2228 U.S. District Court for the Northern District of Illinois (D.D.C. Jan. 16, 2002)
Case details for

In re Lorazepam Clorazepate Antitrust Litigation

Case Details

Full title:IN RE LORAZEPAM CLORAZEPATE ANTITRUST LITIGATION ADVOCATES HEALTH CARE…

Court:United States District Court, D. Columbia

Date published: Jan 16, 2002

Citations

Case Number MDL 1290, Misc. No. 99-276 (TFH/JMF) Case Number 1:99-CV-00790 Consolidated with Case Number 99 C2228 U.S. District Court for the Northern District of Illinois (D.D.C. Jan. 16, 2002)